Martin Possienke
Martin Possienke
company pay potential understand
I can't understand why one would pay so much for a company that has below-average potential growth.
christmas expected liquid outlook recovery season shows
It shows the expected recovery in the Christmas season in liquid crystals. But the outlook is a little disappointing.
bad certainly given high percent portfolio positive product target
The buyback is certainly a positive for the shares, and the profitability target of 20 percent is not bad given that Schering's product portfolio does not have many new drugs with high margins.